← FDA DRUG APPROVALS

FDA NDA · NDA022080

RECLAST

Sponsor: SANDOZ

APPLICATION
NDA022080
TYPE
NDA
ORIGINAL APPROVAL
2007-08-17
LATEST ACTION
2007-08-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

RECLASTPrescription
ZOLEDRONIC ACID 5MG/100ML · INJECTABLE · INJECTION

Approval history

2007-08-17Type 6 - New Indication (no longer used) · Original · standardSummary ReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →